Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...
Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.
Mughal ruler Aurangzeb’s grave in Maharashtra’s Khuldabad has become a target of fringe right-wing groups, who are demanding its demolition. The 17th-century emperor is once again back in the news and ...
Newspoint on MSN12h
Weight loss drug launched in India, will reduce sagging fat, weight will reduce up to 21 kg, know the price and where to get itIn India, around 101 million people suffer from diabetes. More than half of these patients do not have their blood sugar ...
American pharmaceutical company Eli Lilly has launched its drug, Mounjaro, in India. Mounjaro is administered as a ...
TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial ...
Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback